Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Gains from Investment Securities (2016 - 2026)

OptimizeRx's Gains from Investment Securities history spans 10 years, with the latest figure at $5000.0 for Q2 2025.

  • On a quarterly basis, Gains from Investment Securities fell 98.8% to $5000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $448000.0, a 41.89% decrease, with the full-year FY2024 number at $716297.0, up 365.6% from a year prior.
  • Gains from Investment Securities hit $5000.0 in Q2 2025 for OptimizeRx, down from $87000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for OPRX hit a ceiling of $8.5 million in Q1 2022 and a floor of -$4.0 million in Q2 2022.
  • Historically, Gains from Investment Securities has averaged $290611.9 across 5 years, with a median of $113500.0 in 2024.
  • The widest YoY moves for Gains from Investment Securities: up 4340.37% in 2022, down 228001.14% in 2022.
  • Tracing OPRX's Gains from Investment Securities over 5 years: stood at -$1.6 million in 2021, then soared by 371.13% to $4.3 million in 2022, then tumbled by 96.13% to $167000.0 in 2023, then skyrocketed by 94.01% to $324000.0 in 2024, then crashed by 98.46% to $5000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for OPRX at $5000.0 in Q2 2025, $87000.0 in Q1 2025, and $324000.0 in Q4 2024.